4503 — Astellas Pharma Share News
0.000.00%
Last trade - 00:00Brief: Pfizer and Astellas announce positive results from phase 3ev-303 clinical trial for Padcev in combination with Keytruda
Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients
Brief: Astellas Pharma Inc - Astellas Confirms Phase 2 Gleam Trial Did Not Meet Primary Endpoint Of Overall Survival In Patients With Metastatic Pancreatic Cance
Brief: Vyloy (Zolbetuximab) Now Funded In Ontario And Quebec For Advanced Gastric Cancer
Brief: Pfizer Says Padcev Plus Keytruda Improves Survival for Certain Bladder Cancer Patients Pre/Post-Surgery
Pfizer's combination therapy improves survival in bladder cancer trial
Table: Astellas -Q1 group results (IFRS)
Japan national sentenced to 3-1/2 years in prison in China has no plan to appeal, Kyodo says (updated)
Japan national sentenced to 3-1/2 years in prison in China has no plan to appeal, Kyodo says
Factbox: Foreign firms' executives entangled in Chinese probes
Factbox: Foreign firms' executives entangled in Chinese probes
Japan says 'extremely regrettable' Japanese national was found guilty in China
China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei says (updated)
China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei says
Brief: Xtandi® Plus Leuprolide Significantly Improves Survival Outcomes In Men With Non-Metastatic Hormone-Sensitive Prostate Cancer With High-Risk Biochemical Recurrence
Brief: Astellas Pharma Inc - Sales In U.S. Of Izervay (Avacincaptad Pegol Intravitreal Solution) For Treatment Of Geographic Atrophy (Ga) Secondary To Age-Related Macular Degeneration In Q1 Of Fy2025 Was ¥15.9 Billion/ $110 Million
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy
Factbox: Trump's tariffs and threatened trade actions